NewsNTech
NetworkNewsAudio has published an Audio Press Release (APR) featuring Onco-Innovations Limited (CBOE CA: ONCO; OTCQB: ONNVF), placing the company at the center of a broader conversation about PNKP inhibitors and their role in oncology drug development.
The release, distributed through IBN and originating out of Austin, Texas on June 26, 2026, carries the title "Next-Generation DNA Repair Therapies Open New Frontiers in Oncology." The APR and Its Focus The Audio Press Release format is NetworkNewsAudio's vehicle for translating written corporate and sector news into audio content for investor and industry audiences.
This particular installment takes DNA repair therapy as its subject, framing PNKP inhibition as an emerging area within oncology drug pipelines.
The APR does not stand alone as a product announcement; it positions Onco-Innovations Limited within a field-level discussion of where next-generation cancer therapeutics may be heading.
Keep reading